Nextgen (TA:NXGN) — Market Cap & Net Worth
Market Cap & Net Worth: Nextgen (NXGN)
Nextgen (TA:NXGN) has a market capitalization of $1.32 Million (ILA490.55 Million) as of July 30, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30378 globally and #449 in its home market, demonstrating a -13.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nextgen's stock price ILA45.00 by its total outstanding shares 10901184 (10.90 Million). Review total liabilities of Nextgen to assess the company's total debt and financial obligations.
Nextgen Market Cap History: 2015 to 2026
Nextgen's market capitalization history from 2015 to 2026. Data shows change from $47.66 Million to $1.32 Million (-26.21% CAGR).
Nextgen Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nextgen's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NXGN by Market Capitalization
Companies near Nextgen in the global market cap rankings as of July 30, 2026.
Key companies related to Nextgen by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #182 globally with a market cap of $128.14 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #282 globally with a market cap of $91.30 Billion USD ( €78.09 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #342 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Intuitive Surgical Inc | NASDAQ:ISRG | $128.14 Billion | $361.80 |
| #282 | EssilorLuxottica S. A. | PA:EL | $91.30 Billion | €168.65 |
| #342 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €81.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Nextgen Historical Marketcap From 2015 to 2026
Between 2015 and today, Nextgen's market cap moved from $47.66 Million to $ 1.32 Million, with a yearly change of -26.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA1.32 Million | -14.12% |
| 2025 | ILA1.53 Million | -9.81% |
| 2024 | ILA1.70 Million | -55.98% |
| 2023 | ILA3.86 Million | -94.15% |
| 2022 | ILA65.97 Million | -55.05% |
| 2021 | ILA146.77 Million | -41.88% |
| 2020 | ILA252.51 Million | +805.66% |
| 2019 | ILA27.88 Million | -9.56% |
| 2018 | ILA30.83 Million | -0.34% |
| 2017 | ILA30.93 Million | +53.12% |
| 2016 | ILA20.20 Million | -57.62% |
| 2015 | ILA47.66 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 29th, 2026 the market cap of Nextgen was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.32 Million USD |
| MoneyControl | $1.32 Million USD |
| MarketWatch | $1.32 Million USD |
| marketcap.company | $1.32 Million USD |
| Reuters | $1.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nextgen
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.